Autoantibodies directed against the nicotinic acetylcholine receptor (AChR-Ab), found in 80% of patients, along with muscle-specific tyrosine kinase (MuSK-Ab) and low-density lipoprotein receptor-related protein 4 (LRP4-Ab) serve as diagnostic markers for MG. The gene discussed is LRP4; the disease is myasthenia gravis.